Lexicon Pharmaceuticals, Inc.
USD1.85
-0.04 (-2.12%)
CEO
Michael S. Exton
IPO Date
2000-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.89
Prev. Close
$1.89
Day Low
$1.81
Day High
$1.93
52W Low
$0.64
52W High
$2.53
Market Cap
$0.82B
Volume
2.65M
| Acquired |
| 408,434.7 |
| $0.00 |
| 8 May 2026 | Artal Participations S.a r.l. | director, 10 percent owner: | M-Exempt | Disposed | 408,434.7 | $0.00 |
| 4 May 2026 | Cheung Ivan | director | A-Award | Acquired | 35,714 | $0.00 |
| 4 May 2026 | Cheung Ivan | director | A-Award | Acquired | 43,478 | $1.61 |
| 4 May 2026 | Swain Judith L | director | A-Award | Acquired | 35,714 | $0.00 |
| 4 May 2026 | Swain Judith L | director | A-Award | Acquired | 43,478 | $1.61 |
| 4 May 2026 | Sullivan Diane E. | director | A-Award | Acquired | 35,714 | $0.00 |
| 4 May 2026 | Sullivan Diane E. | director | A-Award | Acquired | 43,478 | $1.61 |
| 4 May 2026 | DEBBANE RAYMOND | director | A-Award | Acquired | 35,714 | $0.00 |